You have 9 free searches left this month | for more free features.

City

Ramat Gan (2)

Newcastle (1)

Condition

Acute Myelogenous Leukemia (1)

Acute Myeloid Leukemia (1)

Allogeneic Stem Cell Transplantation (1)

Chronic Myelomonocytic Leukemia (1)

Higher Risk Myelodysplastic Syndrome (1)

Myelogenous Leukemia, Acute (1)

Recurrent Acute Myeloid Leukemia (1)

Refractory Acute Myeloid Leukemia (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Sheba Medical Center (2)

Race Oncology Ltd (1)

Collaborator

Race Oncology Ltd (2)

Astex Pharmaceuticals, Inc. (1)

Intervention

bisantrene (2)

bisantrene dihydrochloride (high dose) (1)

bisantrene dihydrochloride (low dose) (1)

clofarabine (1)

cytarabine hydrochloride (1)

decitabine and cedazuridine (1)

fludarabine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

Bisantrene

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

Recruiting

Acute Myeloid Leukemia
+4 more

Bisantrene Dihydrochloride (high dose)
+3 more

Newcastle, New South Wales, Australia

Calvary Mater

Jul 14, 2022

Myelogenous Leukemia, Acute Trial in Ramat Gan (Bisantrene, Fludarabine, Clofarabine)

Recruiting

Myelogenous Leukemia, Acute

Bisantrene
+2 more

Ramat Gan, Israel

Chaim Sheba Medical Center

Sep 21, 2021

Acute Myelogenous Leukemia, Allogeneic Stem Cell Transplantation Trial in Ramat Gan (Bisantrene)

Completed

Acute Myelogenous Leukemia
Allogeneic Stem Cell Transplantation

Bisantrene

Ramat Gan, Israel

Chaim Sheba Medical Center

Aug 6, 2020